Pfizer Asks US FDA To Approve Covid-19 Vaccine Booster Shot For 5-11 year Kids


The pharmaceutical company ‘Pfizer Inc.’ has asked the Food and Drug Administration (FDA) of the United States for the emergency use authorization of a booster shot of the company’s corona virus vaccine in the children between the ages of 5 to 11 years, which has been setting in motion an effort for providing the extra protection to the kids.

Pfizer along with BioNTech has submitted the data to the Food and Drug Administration (FDA) of the United States from a study that has showed a third dose booster vaccine shot, which has been given around 6 months after the second dose of the vaccine provided a strong immune response.

Both the companies are also planning to submit the data to the European Medicines Agency and several other regulators across the world and they also said that, no new safety concerns had been identified.

According to the Centers for Disease Control and Prevention (CDC) of the United States, the campaign of the United States for the purpose of immunizing the children has tapered off and with 28 percent of the children ages between 5 years to 11 years fully vaccinated.

See also  Zoetis Inc., Donates Animal Covid-19 Vaccine Candidate to 70 Zoos in US

The US CDC also said, lesser than a quarter of the children between 12 to 17 years of age, who are already eligible for the booster vaccine have received the booster vaccine shots.